Detection of anabolic steroid abuse using a yeast transactivation system

Steroids

Volumn 73, Issue 11, 2008, Pages 1143-1147

  Zierau, Oliver ^a   Lehmann, Sylvi ^a   Vollmer, Günter ^a   Schänzer, Willhelm ^b   Diel, Patrick ^c  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b GERMAN SPORT UNIVERSITY COLOGNE   (Germany)

^c Institute of Cardiovascular Research and Sports Medicine   (Germany)

Author keywords

Anabolic steroid; Doping; Reporter gene system; Urine

Indexed keywords

1 TESTOSTERONE; ANABOLIC AGENT; ANDROGEN RECEPTOR; ANDROSTANOLONE; BUFFER; DRUG METABOLITE; ESTROGEN; GESTAGEN; GLUCOCORTICOID; METANDIENONE; MINERALOCORTICOID; NORBOLETONE; STANOZOLOL; TETRAHYDROGESTRINONE;

ANDROGEN GENE; ARTICLE; ATHLETE; COST EFFECTIVENESS ANALYSIS; DOPING; DRUG ABUSE; GAS CHROMATOGRAPHY; GENE; HUMAN; MASS SPECTROMETRY; REPORTER GENE; TRANSACTIVATION; URINALYSIS; YEAST; YEAST TRANSACTIVATION SYSTEM;

ANABOLIC AGENTS; ANDROGENS; BETA-GALACTOSIDASE; BIOLOGICAL ASSAY; DESIGNER DRUGS; DIHYDROTESTOSTERONE; DOSE-RESPONSE RELATIONSHIP, DRUG; GENES, REPORTER; GESTRINONE; HUMANS; MALE; NORPREGNENES; RECEPTORS, ANDROGEN; SACCHAROMYCES CEREVISIAE; SENSITIVITY AND SPECIFICITY; SUBSTANCE ABUSE DETECTION; TESTOSTERONE; TRANS-ACTIVATION (GENETICS);

EID: 46749138616     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.steroids.2008.04.015     Document Type: Article

References (11)

1. Maravelias C., Dona A., Stefanidou M., and Spiliopoulou C. Adverse effects of anabolic steroids in athletes. A constant threat. Toxicol Lett 158 (2005) 167-175
2. Deventer K., Eenoo P.V., and Delbeke F.T. Screening for anabolic steroids in doping analysis by liquid chromatography/electrospray ion trap mass spectrometry. Biomed Chromatogr 20 (2006) 429-433
3. World Anti-Doping Agency Statistics, Overview of the 2006 adverse analytical findings reported by accredited laboratories (http://www.wada-ama.org/rtecontent/document/LABSTATS_2006.pdf, accessed in January 2008).
4. Boos C., Wulff P., Kujath P., and Bruch H.-P. Medikamentenmißbrauch beim Freizeitsportler im Fitneßbereich. Deutsches Ärzteblatt 95 (1998) A-953-A-957
5. Kerr J.M., and Congeni J.A. Anabolic-androgenic steroids: use and abuse in pediatric patients. Pediatr Clin North Am 54 (2007) 771-785
6. Nationalen Anti-Doping-Agentur (NADA) Reports, Doping-Bilanz der NADA für den Deutschen Sport 2006 (http://www.nada-bonn.de/fileadmin/user_upload/Presse/070327_NADA_Dopingbilanz_2006.pdf, accessed in January 2008).
7. World Anti-Doping Agency Reports, Report of the WADA working group on anti-doping costs, 2006 (http://www.wada-ama.org/rtecontent/document/Report_WG_Costs_231106_en.pdf, accessed in January 2008).
8. Borges C.R., Miller N., Shelby M., Hansen M., White C., Slawson M.H., et al. Analysis of a challenging subset of World Anti-Doping Agency-banned steroids and antiestrogens by LC-MS-MS. J Anal Toxicol 31 (2007) 125-131
9. Sohoni P., and Sumpter J.P. Several environmental oestrogens are also anti-androgens. J Endocrinol 158 (1998) 327-339
10. Diel P., Friedel A., Geyer H., Kamber M., Laudenbach-Leschowsky U., Schanzer W., et al. Characterisation of the pharmacological profile of desoxymethyltestosterone (Madol), a steroid misused for doping. Toxicol Lett 169 (2007) 64-71
11. Zierau O., Morrissey C., Watson R.W., Schwab P., Kolba S., Metz P., et al. Antiandrogenic activity of the phytoestrogens naringenin, 6-(1,1-dimethylallyl)naringenin and 8-prenylnaringenin. Planta Med 69 (2003) 856-858